Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection

International Journal of Colorectal Disease

Volumn 28, Issue 1, 2013, Pages 35-42

  Elliott, Giles O ^a   Johnson, Ian T ^a   Scarll, Jane ^a   Dainty, Jack ^a   Williams, Elizabeth A ^c   Garg, D ^b   Coupe, Amanda ^b   Bradburn, David M ^d   Mathers, John C ^b   Belshaw, Nigel J ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d WANSBECK GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Colorectal cancer; DNA methylation; Epigenetics; Stool

Indexed keywords

ADENOMA; ADULT; AGED; APC GENE; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CDH1 GENE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA DETERMINATION; DNA EXTRACTION; DNA METHYLATION; ESR1 GENE; FECES ANALYSIS; FEMALE; GENE ACTIVITY; GENETIC ANALYSIS; HPP1 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MLH1 GENE; MULTIVARIATE ANALYSIS; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TMEFF2 GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMATOUS POLYPS; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CPG ISLANDS; DISCRIMINANT ANALYSIS; DNA METHYLATION; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; FECES; FEMALE; GENES, APC; GENETIC MARKERS; HUMANS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872601905     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1532-5     Document Type: Article

References (54)

1. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112(2):594-642. doi: 10.1053/gast.1997.v112.agast970594
2. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD (1993) Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 269(10):1262-1267. doi: 10.1001/jama.269.10. 1262
3. Allison JE, Feldman R, Tekawa IS (1990) Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med 112(5):328-333
4. Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1996) A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334(3):155-159. doi: 10.1056/NEJM199601183340304
5. Lieberman DA, Weiss DG (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345(8):555-560. doi: 10.1056/NEJMoa010328
6. Young GP, John DJBS, Winawer SJ, Rozen P (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97(10):2499-2507. doi: 10.1111/j.1572-0241.2002.06046.x
7. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256(5053):102-105. doi: 10.1126/science.1566048
8. Villa E, Dugani A, Rebecchi A, Vignoli A, Grottola A, Buttafoco P, Losi L, Perini M, Trande P, Merighi A, Lerose R, Manenti F (1996) Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology 110(5):1346-1353. doi: 10.1053/gast.1996.v110.pm8613038
9. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ Jr, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346(5):311-320. doi: 10.1056/NEJMoa012294
10. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, the Colorectal Cancer Study G (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351(26):2704-2714. doi: 10.1056/NEJMoa033403
11. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL (2008) Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 149(7):441-450, W481
12. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95(20):11891-11896. doi: 10.1073/pnas.95.20.11891
13. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li L-C, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R (2005) Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res 11(18):6582-6588. doi: 10.1158/1078-0432.ccr-05-0658
14. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E, Argani P, Sukumar S (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64(13):4442-4452. doi: 10.1158/0008-5472.can-03-3341
15. Grote HJ, Schmiemann V, Geddert H, Bocking R, Kappes R, Gabbert HE, Sarbia M (2006) Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Canc Cytopathol 108(2):129-134. doi: 10.1002/cncr.21717
16. Jubb AM, Quirke P, Oates AJ (2003) DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility. Ann NY Acad Sci 983(1):251-267
17. Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M (2006) p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Biochem Biophys Res Commun 339(3):790-796. doi: 10.1016/j.bbrc.2005.11.072
18. Belshaw NJ, Elliott GO, Williams EA, Bradburn DM, Mills SJ, Mathers JC, Johnson IT (2004) Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. Canc Epidemiol Biomarkers Prev 13(9):1495-1501
19. Chang E, Il Park D, Kim YJ, Kim BK, Park JH, Kim HJ, Cho YK, Il Sohn C, Jeon WK, Kim BI, Kim HD, Kim DH, Kim YH (2010) Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepato-Gastroenterol 57(101):720-727
20. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Canc Inst 97(15):1124-1132. doi: 10.1093/jnci%2Fdji204
21. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruine AP, Smits KM, Khalidde Bakker CAJ, Jonkers DMAE, Stockbrugger RW, Meijer GA, Oort FA, Iacobuzio-Donahue C, Bierau K, Herman JG, Baylin SB, Van Engeland M, Schuebel KE, Ahuja N (2009) Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 69(11):4691-4699. doi: 10.1158/0008-5472.can-08-0142
22. Huang ZH, Li LH, Wang JF (2007) Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci 52(9):2287-2291. doi: 10.1007/s10620-007-9755-y
23. Huang ZH, Li LH, Yang F, Wang JF (2007) Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol 13(6):950-954
24. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, Lamerz R, Kolligs FT (2005) Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 3(2):142-149. doi: 10.1016/S1542-3565(04)00624-X
25. Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Lee JF, Sung JJ (2004) Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study. Clin Chem 50(11):2179-2182. doi: 10.1373/clinchem.2004.039305
26. Leung WK, To K-F, Man EPS, Chan MWY, Hui AJ, Ng SSM, Lau JYW, Sung JJY (2007) Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 102(5):1070-1076. doi: 10.1111/j.1572-0241.2007.01108.x
27. Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Muhlthaler M, Ofner D, Margreiter R, Widschwendter M (2004) Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363(9417):1283-1285
28. Oberwalder M, Zitt M, Wontner C, Fiegl H, Goebel G, Kohle O, Muhlmann G, Ofner D, Margreiter R, Muller HM (2008) SFRP2 methylation in fecal DNA: a marker for colorectal polyps. Int J Color Dis 23:15-19. doi: 10.1007/s00384-007-0355-2
29. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM (2005) Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from Patients with colorectal polyps. Clin Cancer Res 11(3):1203-1209
30. Wang DR, Tang D (2008) Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol 14(4):524-531. doi: 10.3748/wjg.14.524
31. Ahlquist D, Skoletsky J, Boynton K, Harrington J, Mahoney D, Pierceall W, Thibodeau S, Shuber A (2000) Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119(5):1219-1227. doi: 10.1053/gast.2000.19580
32. Klaassen CHW, Jeunink MAF, Prinsen CFM, Ruers TJM, Tan ACITL, Strobbe LJA, Thunnissen FBJM (2003) Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem 49(7):1185-1187. doi: 10.1373/49.7.1185
33. Belshaw NJ, Elliott GO, Foxall RJ, Dainty JR, Pal N, Coupe A, Garg D, Bradburn DM, Mathers JC, Johnson IT (2008) Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer 99(1):136-142. doi: 10.1038/sj.bjc.6604432
34. Ahuja N, Issa JP (2000) Aging, methylation and cancer. Histol Histopathol 15(3):835-842
35. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa J-PJ (1998) Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58(23):5489-5494
36. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA (2001) Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61(9):3573-3577
37. Worthley DL, Whitehall VLJ, Buttenshaw RL, Irahara N, Greco SA, Ramsnes I, Mallitt KA, Le Leu RK, Winter J, Hu Y, Ogino S, Young GP, Leggett BA (2010) DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 29(11):1653-1662. doi: 10.1038/onc.2009.449
38. Nakagawa H, Nuovo GJ, Zervos EE, Martin EW, Salovaara R, Aaltonen LA, de la Chapelle A (2001) Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 61(19):6991-6995
39. Kang MY, Lee BB, Ji YI, Jung EH, Chun H-K, Song SY, Park S-E, Park J, Kim D-H (2008) Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 112(8):1699-1707. doi: 10.1002/cncr.23335
40. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TO, Esteller M, Lothe RA (2004) A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Canc 3:28
41. Konishi K, Shen L, Jelinek J, Watanabe Y, Ahmed S, Kaneko K, Kogo M, Takano T, Imawari M, Hamilton SR, Issa J-PJ (2009) Concordant DNA methylation in synchronous colorectal carcinomas. Canc Prev Res 2(9):814-822. doi: 10.1158/1940-6207.capr-09-0054
42. Moriyama T, Matsumoto T, Nakamura S, Jo Y, Mibu R, Yao T, Iida M (2007) Hypermethylation of p14(ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Dis Colon Rectum 50(9):1384-1392
43. Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R, Kaji E, Kondo Y, Yamamoto K (2011) DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis:n/a-n/a. doi: 10.1002/ibd.21573
44. Team RDC (2006) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.
45. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7(1):21-33. doi: 10.1038/nrg1748
46. Ahlquist DA, Klatt KK, Harrington JJ, Cunningham JM (2002) Novel use of hypermethylated DNA markers in stool for detection of colorectal cancer: a feasibility study. Gastroenterology 122(suppl 1):A40
47. Boynton KA, Summerhayes IC, Ahlquist DA, Shuber AP (2003) DNA Integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 49(7):1058-1065. doi: 10.1373/49.7.1058
48. Zou H, Harrington JJ, Klatt KK, Ahlquist DA (2006) A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening. Canc Epidemiol Biomarkers Prev 15(6):1115-1119. doi: 10.1158/1055-9965.epi-05-0992
49. Hellebrekers DMEI, Lentjes MHFM, van den Bosch SM, Melotte V, Wouters KAD, Daenen KLJ, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalidde Bakker CAJ, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Meijer GA, Baylin SB, Herman JG, de Bruïne AP, van Engeland M (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 15(12):3990-3997. doi: 10.1158/1078-0432.ccr-09-0055
50. Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capella G (2010) Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Canc 9(3):168-176. doi: 10.3816/CCC.2010.n.023
51. Loktionov A (2007) Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int J Cancer 120(11):2281-2289. doi: 10.1002/ijc.22647
52. Rosen K, Shi W, Calabretta B, Filmus J (2002) Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J Biol Chem 277(48):46123-46130. doi: 10.1074/jbc.M207883200
53. Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ (1998) Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res 58(15):3391-3400
54. Peli J, Schroter M, Rudaz C, Hahne M, Meyer C, Reichmann E, Tschopp J (1999) Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 18(7):1824-1831. doi: 10.1093/emboj/18.7.1824